Kymera Therapeutics, Inc. · NASDAQ:KYMR
Adams Brian sold 6,371 Kymera Therapeutics, Inc. shares (Form 4)
Traded Sep 4, 2026 · Filed Sep 4, 2026
On Sep 4, 2026, Adams Brian (Chief Legal Officer) sold 6,371 Kymera Therapeutics, Inc. shares at an average US$116.83 for US$744K, leaving 50,254 shares. Filed Sep 4, 2026 (Form 4).
- Sold
- 6,371 shares
- Price
- US$116.83 average (US$115.55 to US$117.57)
- Value
- US$744K
- Holding after
- 50,254 shares
- Trading plan
- No
- Role
- Chief Legal Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Common Stock | Sale | 1,209 | US$115.55 | 55,416 | Direct |
| Sep 4, 2026 | Common Stock | Sale | 3,025 | US$116.81 | 52,391 | Direct |
| Sep 4, 2026 | Common Stock | Sale | 2,137 | US$117.57 | 50,254 | Direct |
Source
Related
- Kymera Therapeutics, Inc.
- Adams Brian
- Kymera Therapeutics, Inc. shareholders
- Form 4 · Mainolfi Nello · Oct 1, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Sep 8, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Atlas Venture Fund X, L.P. · Aug 13, 2026
- Form 4 · Rooney Terence · Jul 27, 2026